Hidalgo HH

Language: Spanish
References: 10
Page: 777-783
PDF size: 703.40 Kb.

ABSTRACT

Background: in the last 10 years, the Epidemiological Surveillance System Abangares not report suspected cases of whooping cough or whooping cough syndrome, according to statistics from the Ministry of Health and CCSS (Abangares), there were 14 suspected cases of the infection, which caused an outbreak alarming to the public.
Methods: analyzed a total of 14 records generated by the system of local information, including: medical records, research records, laboratory tests. Defined criteria for Pertussis or whooping cough syndrome was based cough of any development time, usually 2 or more weeks, with at least one of the following symptoms: paroxysms, inspiratory noise, post-cough vomiting, apnea and cyanosis without other apparent cause.
Results: were diagnosed 14 cases of whooping cough and whooping cough syndrome with EV-01 ballot, according to the clinical manifestations of infection (symptoms and signs) was documented that 86% of such cases had paroxysmal cough, 64.2% vomiting after -cough, 36% apnea, inspiratory stridor 28.6%, 7.1% cyanosis. The cases occurred between epidemiological weeks 17 and 23 2007.
Conclusion: 92.8% of the cases were indigenous. 14.3% presented positive PCR for Bordetella pertussis, conducted by nasopharyngeal aspirate was not performed immunofluorescence or culture to be a Health. It is important to assess endemic channels of Upper Respiratory Infections and may be masking cases catarrhal stage of whooping cough that 2 to 4 weeks later we have to diagnose the patients, who already existed, resulting in an increase in transmission to the population. It is important to have high coverage in the post-delivery with acellular DPT Abangares reported as 29% cases in children under 1 year, where the vaccine was being launched in maternity centers.

REFERENCES

1. Academia Americana de Pediatría 2004. Tos Ferina. En: Pickering LK (ed). Red Book (Libro Rojo). Informe del Comité de Enfermedades Infecciosas para 2003. 26 ed. México: Intersistemas: 641-656.

2. Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age, Nicholas Wood, MB BS, FRACP,*† Peter McIntyre, MB BS, FRACP, FAFPHM, PhD,*† Helen Marshall, MB BS, DCH, MPH,§ and Don Roberton, MD, FRACP, FRCPA.

3. Ávila Agüero María Luisa, Tosferina: Infección reemergente Acta Médica Costarricense, vol. 49, núm. 3, julio-septiembre, 2007, pp. 134-135, Colegio de Médicos y Cirujanos de Costa Rica.

4. Aumento de las Infecciones Respiratorias Agudas (IRA). Vigilancia epidemiológica de tos ferina, Red de Sociedades Científicas Médicas de Venezuela Comisión de Epidemiología ALERTA EPIDEMIOLÓGICA Nº 154, 17 de octubre de 2010.

5. Benenson, A.S. 1997. Manual para el control de las enfermedades transmisibles, Decimosexta edición. OPS. Publicación Científica N 564. pp. 446-451.

6. Decreto Ejecutivo N 14496-SPPS. Enfermedades de Declaración Obligatoria. La Gaceta, República de Costa Rica, San José, 29 de Abril de 1983.

7. Fernández-Cano MI, Armadans- Gil L, Alvarez-Bartolomé M, Rodrigo-Pendás JA, Campins Martí-M. Enferm Infecc Microbiol Clin. 2014 18 de enero pii:. S0213- 005X (13) 00386-8. doi: 10.1016/j. eimc.2013.11.006.

8. Ministerio de Salud, Caja Costarricense de Seguro Social. 1998. Protocolos de Vigilancia Epidemiológica.

9. Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina, Enferm Infecc Microbiol Clin. 2013;31(4):240– 253.

10. TOS FERINA: UN PROBLEMA EMERGENTE, Revista Española de Salud Pública, vol. 76, núm. 4, julioagosto, 2002Ministerio de Sanidad, Servicios Sociales e Igualdad España, Ricardo Escorihuela Esteban, Ma. Verísima Barajas Sánchez.